Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases.
Angiogenesis
Brain metastasis
Glioblastoma
Hypoxia
Physiological MRI
Journal
Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
25
01
2021
accepted:
02
04
2021
revised:
29
03
2021
pubmed:
24
4
2021
medline:
8
2
2022
entrez:
23
4
2021
Statut:
ppublish
Résumé
Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain tumors in adults. GB and BM may appear similar in conventional magnetic resonance imaging (cMRI). Their management strategies, however, are quite different with significant consequences on clinical outcome. The aim of this study was to evaluate the usefulness of a previously presented physiological MRI approach scoping to obtain quantitative information about microvascular architecture and perfusion, neovascularization activity, and oxygen metabolism to differentiate GB from BM. Thirty-three consecutive patients with newly diagnosed, untreated, and histopathologically confirmed GB or BM were preoperatively examined with our physiological MRI approach as part of the cMRI protocol. Physiological MRI biomarker maps revealed several significant differences in the pathophysiology of GB and BM: Central necrosis was more hypoxic in GB than in BM (30 %; P = 0.036), which was associated with higher neovascularization activity (65 %; P = 0.043) and metabolic rate of oxygen (48 %; P = 0.004) in the adjacent contrast-enhancing viable tumor parts of GB. In peritumoral edema, GB infiltration caused neovascularization activity (93 %; P = 0.018) and higher microvascular perfusion (30 %; P = 0.022) associated with higher tissue oxygen tension (33 %; P = 0.020) and lower oxygen extraction from vasculature (32 %; P = 0.040). Our physiological MRI approach, which requires only 7 min of extra data acquisition time, might be helpful to noninvasively distinguish GB and BM based on pathophysiological differences. However, further studies including more patients are required.
Identifiants
pubmed: 33891264
doi: 10.1007/s11307-021-01604-1
pii: 10.1007/s11307-021-01604-1
pmc: PMC8410731
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
787-795Informations de copyright
© 2021. The Author(s).
Références
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12550-5
pubmed: 25114226
J Cereb Blood Flow Metab. 2017 Feb;37(2):632-643
pubmed: 27317652
Neuro Oncol. 2009 Dec;11(6):842-52
pubmed: 19229057
Radiother Oncol. 2012 Feb;102(2):168-79
pubmed: 21996522
Eur Radiol. 2018 Sep;28(9):3819-3831
pubmed: 29619517
PLoS One. 2014 Dec 15;9(12):e115018
pubmed: 25506702
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Front Oncol. 2020 May 15;10:796
pubmed: 32500034
Stroke. 1981 Mar-Apr;12(2):211-7
pubmed: 7233466
Neuro Oncol. 2011 Dec;13(12):1339-48
pubmed: 21914639
Clin Transl Oncol. 2016 Nov;18(11):1062-1071
pubmed: 26960561
Neurosurg Focus. 2019 Dec 1;47(6):E14
pubmed: 31786560
Neuroimage. 2004 May;22(1):434-42
pubmed: 15110036
J Natl Compr Canc Netw. 2011 Apr;9(4):414-27
pubmed: 21464146
Magn Reson Med. 2006 Nov;56(5):1145-50
pubmed: 17029231
Radiology. 2017 Jun;283(3):799-809
pubmed: 27982759
Neuroradiology. 2015 Jul;57(7):697-703
pubmed: 25845813
Neuro Oncol. 2017 Feb 1;19(2):162-174
pubmed: 28391295
Curr Treat Options Neurol. 2001 Jan;3(1):89-99
pubmed: 11123862
Eur Radiol. 2019 Aug;29(8):4133-4140
pubmed: 30488111
Neuro Oncol. 2018 Oct 9;20(11):1536-1546
pubmed: 29718366
Sci Rep. 2017 Aug 17;7(1):8508
pubmed: 28819189
J Neurooncol. 2000 Dec;50(3):265-73
pubmed: 11263507
Radiology. 2020 Apr;295(1):181-189
pubmed: 32068505
J Neurosurg. 2014 Nov;121(5):1115-23
pubmed: 25192475
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
J Cereb Blood Flow Metab. 2018 Mar;38(3):422-432
pubmed: 28273720
AJNR Am J Neuroradiol. 2008 Jun;29(6):1140-1
pubmed: 18388221
Histol Histopathol. 2009 Jun;24(6):693-706
pubmed: 19337968
NMR Biomed. 2017 Nov;30(11):
pubmed: 28805936
Methods Mol Biol. 2011;763:417-22
pubmed: 21874468
Nat Rev Neurosci. 2007 Aug;8(8):610-22
pubmed: 17643088
Clin Neuroradiol. 2011 Sep;21(3):123-39
pubmed: 21538040
J Clin Neurosci. 2018 Sep;55:86-92
pubmed: 29934058